Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03734822|
Recruitment Status : Completed
First Posted : November 8, 2018
Results First Posted : March 14, 2019
Last Update Posted : March 14, 2019
|Condition or disease||Intervention/treatment||Phase|
|Cystic Fibrosis||Other: End tidal CO2 (EtCO2) Device: Transcutaneous CO2 (TCO2) Diagnostic Test: Capillary CO2 (CapCO2) Diagnostic Test: Arterial blood gas (ABG)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||47 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia|
|Actual Study Start Date :||March 10, 2016|
|Actual Primary Completion Date :||December 20, 2017|
|Actual Study Completion Date :||December 20, 2017|
Cystic fibrosis patients undergoing general anesthesia.
Other: End tidal CO2 (EtCO2)
End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia.
Device: Transcutaneous CO2 (TCO2)
Continuous and noninvasive real-time monitoring of transcutaneous CO2.
Other Name: The SenTec Digital Monitoring System (SDMS)
Diagnostic Test: Capillary CO2 (CapCO2)
Capillary CO2 collected by finger stick and run on the i-STAT handheld blood analyzer.
Diagnostic Test: Arterial blood gas (ABG)
Arterial blood gas collected from the radial artery and run on the i-STAT handheld blood analyzer.
- Accuracy of CO2 Levels [ Time Frame: Immediately following induction of anesthesia ]Looking at the accuracy of CO2 levels assessed via end tidal CO2 (ETCO2), capillary CO2 (Cap-CO2), and transcutaneous CO2 (TCCO2) compared to arterial blood gas (ABG) which is the gold standard.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03734822
|United States, Ohio|
|Nationwide Children's Hospital|
|Columbus, Ohio, United States, 43205|